From the CDC. Huang YA, Zhu W, Smith DK, Harris N, Hoover KW. HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016. MMWR Morb Mortal Wkly Rep 2018;67:1147–1150. DOI: http://dx.doi.org/10.15585/mmwr.mm6741a3 Preexposure prophylaxis (PrEP) with a daily, oral pill containing antiretroviral drugs is highly effective in preventing acquisition of human immunodeficiency virus (HIV) infection (1–4). […]
From HIV.gov. This is only a portion of the article. View the full article here. Spike in new infections could have devastating long-term consequences New research from the Centers for Disease Control and Prevention (CDC) suggests that the recent steep increase in cases of acute hepatitis C virus infection is associated with increases in opioid […]
From HIV.gov. To read the blog in it’s entirety, click here: by Richard Wolitski, Director, OHAIDP & Nathan Fecik, Public Health Advisor, OHAIDP According to guidelines by the Centers for Disease Control and Prevention (CDC), we all should have been tested for HIV at least once in our lives. The National HIV/AIDS Strategy (NHAS) includes, as one of its […]
Dr. Linda Frank is an Associate Professor, Infectious Diseases and Microbiology, Department of Infectious Diseases, Graduate School of Public Health with secondary appointments in School of Nursing, Community and Health Systems, the School of Medicine, Center for Translational Science Institute & the Center for Russian & Eastern European Studies. She is currently the […]
The White House just released the 2016 Progress Report on National HIV/AIDS Strategy and a revised NHAS Indicator Supplement. The Progress Report includes an infographic on major milestones.